Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction Comparison with single-photon emission tomography using Tc99m-sestamibi by Ibrahim, Tareq et al.
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PCardiac Imaging
uantitative Measurement of Infarct Size
y Contrast-Enhanced Magnetic Resonance
maging Early After Acute Myocardial Infarction
omparison With Single-Photon
mission Tomography Using Tc99m-Sestamibi
areq Ibrahim, MD,* Stephan G. Nekolla, PHD,† Mira Hörnke,† Hubertus P. Bülow, MD,†
osef Dirschinger, MD,* Albert Schömig, MD,* Markus Schwaiger, MD, FACC†
unich, Germany
OBJECTIVES The aim of this research was to evaluate kinetics and extent of myocardial contrast
enhancement (CE) in comparison with single-photon emission computed tomography
(SPECT) early after acute myocardial infarction (AMI).
BACKGROUND Quantification of infarct size serves as a surrogate end point in evaluating new therapies of
AMI. Contrast-enhanced magnetic resonance imaging (CeMRI) of the myocardium is a
promising new method for identification of irreversible tissue injury.
METHODS A total of 33 patients were examined by CeMRI and SPECT 7  2 days after AMI and
successful coronary intervention. After gadolinium-diethylenetraimine pentaacetic acid in-
jection (0.2 mmol/kg), continuous short-axis slices of the left ventricle (LV) were acquired
every 7 min up to 42 min using different inversion times (TI). Myocardial CE at each imaging
time point was quantified and compared with corresponding SPECT perfusion defect.
RESULTS All patients showed myocardial CE in the infarct region. A constant TI for CeMRI resulted
in a decrease of signal intensity and extent of CE on late acquisitions. With TI adjustment,
infarct image intensity peaked at 21 min with a contrast of 478% of remote myocardium and
remained at this level up to 42 min after contrast injection (437%); CE extent was stable over
time and agreed well with SPECT within an average difference of 3% of the LV myocardium,
yielding the best correlation at 28 min (r  0.86).
CONCLUSIONS In patients after AMI and successful reperfusion, CE is stable over time and matches well
with SPECT perfusion defect; CeMRI under standardized conditions can accurately assess
myocardial infarct size in vivo and may be attractive for serving as a surrogate end point early
after AMI. (J Am Coll Cardiol 2005;45:544–52) © 2005 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.10.058Cardiology Foundation
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(oninvasive assessment of myocardial infarct size is an
mportant clinical goal in patients with coronary artery
isease because of its known prognostic value (1). After
cute myocardial infarction (AMI) it allows risk stratifica-
ion and evaluation of myocardial salvage, which has an
mportant impact for patient management due to the
ifferentiation of reversible from nonreversible tissue injury.
everal methods have been introduced for measurement of
nfarct size in humans including electrocardiography, car-
iac enzyme levels, and noninvasive imaging techniques
uch as echocardiography (2). However, all of them provide
ndirect parameters that may not specifically delineate non-
eversible tissue injury.
Nuclear imaging techniques are currently accepted and
alidated clinical tools for the quantification of infarct size
From the *Deutsches Herzzentrum München and 1. Medizinische Klinik des
linikums Rechts der Isar, Technische Universität München, Munich, Germany; and
Nuklearmedizinische Klinik und Poliklinik der Technischen Universität München,
unich, Germany.M
Manuscript received December 14, 2003; revised manuscript received September 7,
004, accepted October 12, 2004.3). Several animal and clinical studies have shown that
9mTc-sestamibi single-photon emission computed tomog-
aphy (SPECT)-assessed myocardial perfusion defects dur-
ng coronary occlusion provides an estimate of myocardium
t risk. Subsequently, injection of 99mTc-sestamibi several
ays after coronary reperfusion allows delineation of the
final” infarct size in close correlation to pathology speci-
ens from both laboratory animals and humans (4,5);
PECT is being used as an end point in various clinical
rials as a measure of the efficacy of reperfusion therapy (6).
uantitative infarct size measured by 99mTc-sestamibi has
lso been shown to predict subsequent mortality after
eperfusion therapy (7).
Recently, contrast-enhanced magnetic resonance imaging
CeMRI) has been applied to identify myocardial necrosis,
hich represents a promising alternative to established
uclear methods providing a high-resolution delineation of
nfarct extent (8–17). However, the clinical role of delayed
nhancement in acute and subacute myocardial infarction
MI) is much less defined than it is in patients with chronicI. Studies in animals performed one to two days after
r
a
g
D
(
m
E
s
c
f
c
t
t
n
p
i
i
c
t
c
A
e
b
M
P

s
t
i
a
e
s
a
M
t
r
a
c
I
s
E
a
e
a
g
s
s
a
s
f
1
fi
D
B
C
m
4
e
d
d
t
e
4
S
2
i
S
c
E
h
w
t
s
p
f
D
p
t
o
m
s
t
T
m
a
e
e
s
t
545JACC Vol. 45, No. 4, 2005 Ibrahim et al.
February 15, 2005:544–52 Quantification of Infarct Size by MRIeperfused infarction showed that regions of enhancement
fter administration of extracellular contrast agents such as
adolinium-diethylenetriamine pentaacetic acid (Gd-
TPA) are associated with irreversible ischemic injury
8,9), while other studies showed that myocardial enhance-
ent overestimates the infarct zone by 10% to 20% (10).
xperimental comparison of Gd-DTPA with necrosis-
pecific porphyrin-based contrast agents have produced
ontroversial results for the quantitative assessment of in-
arct size (11,12).
Conflicting results were also reported in patient studies
onducted within one week after AMI, which have shown
hat regions of enhancement can recover contractile func-
ion two months later, whereas other investigators observed
o improvement of enhanced regions (13,14).
Many factors may contribute to the disparate results
ublished so far including species differences, methodolog-
cal aspects, or timing of image acquisition after contrast
njection, thus suggesting the need for standardized proto-
ols for the assessment of infarct size (18). The purpose of
his study was to examine the time course of myocardial
ontrast enhancement (CE) in patients with reperfused
MI seven days after myocardial injury and to compare the
xtent of CE with the size of perfusion defects determined
y Tc99m-sestamibi SPECT at the same time.
ETHODS
atient population. A total of 33 consecutive patients (61
12 years of age; 26 men) with first time AMI (onset of
ymptoms 48 h) and successful coronary reperfusion
herapy by coronary stenting on the day of admission were
ncluded in the study. Diagnosis of infarction was based on
cute chest pain, characteristic electrocardiogram changes,
levated creatine kinase (CK), and angiographically demon-
trated partial or complete occlusion of the infarct-related
rtery. Patients with previous MI or contraindication to
RI (pace-maker or claustrophobia) were excluded from
he study. All subjects were examined 7.0  1.5 days after
Abbreviations and Acronyms
AMI  acute myocardial infarction
CE  contrast enhancement
CeMRI  contrast-enhanced magnetic resonance
imaging
CK  creatine kinase
EF  ejection fraction
Gd-DTPA  gadolinium-diethylenetriamine pentaacetic
acid
LV  left ventricle/ventricular
MI  myocardial infarction
MRI  magnetic resonance imaging
SPECT  single-photon emission computed
tomography
TI  inversion timeeperfusion therapy. The study protocol was reviewed and npproved by the local ethics committee. Written informed
onsent was obtained before inclusion in the study.
maging protocols. MRI. Patients were examined in a
upine position with a 1.5-T tomograph (Siemens Sonata,
rlangen, Germany) equipped with ultra-fast gradients and
dedicated cardiac phased-array surface coil. Contiguous
nd-diastolic short-axis slices of the left ventricle (LV) were
cquired from base to apex using an electrocardiogram-
ated segmented TrueFISP inversion recovery sequence for
ensitive assessment of inversion time (TI) changes. Three
lices (slice thickness: 8 mm) per breath hold were acquired
t end expiration (6 to 10 s), altogether 12 to 15 slices per
tudy to cover the entire LV. Image parameters were as
ollows: repetition time (TR) 2.3 ms, excitation time (TE)
.4 ms, image matrix 256 128 interpolated to 256 256,
eld of view 450 mm, flip angle 60°.
After a baseline acquisition, a bolus of 0.2 mmol Gd-
TPA per kg body weight (Magnevist, Schering-AG,
erlin, Germany) was injected into a peripheral vein.
omplete LV image sets were acquired every 7 min until 42
in after injection (imaging time points: 7’, 14’, 21’, 28’, 35’,
2’ min), using four different TIs (250, 300, 350, 400 ms) at
very time point. In order to null normal myocardium, all
atasets were analyzed on a patient-by-patient basis to
efine the best TI at every imaging time point. Based on
his adjustment, the mean TI increased with duration of
xamination (7’: 290; 14’: 297; 21’: 331; 28’: 344; 35’: 375;
2’: 390 ms).
PECT. Resting SPECT studies were performed within
4 h of CeMRI. All patients received an intravenous
njection of 350 MBq of technetium-99m-sestamibi;
PECT acquisitions were performed with a triple-head
amera system (MultiSPECT 3, Siemens Medical Systems,
rlangen, Germany) equipped with low-energy, parallel-
ole collimators 30 min after tracer application. Images
ere acquired in a 64  64 data matrix with an acquisition
ime of 40 s per projection. The image data were recon-
tructed over 180° from 45° right anterior oblique to 45° left
osterior oblique by use of a Butterworth filter with a cutoff
requency of 0.45, order 5.
ata analysis. MRI. Quantitative analysis of MRIs were
erformed by a computer program developed at our insti-
ution (MunichHeart/MRI). Epi- and endocardial contours
f the entire LV were manually traced. Subsequently, the
ean transmural circumferential signal intensity of every
hort-axis slice—excluding the LV outflow tract—was au-
omatically calculated within 36 segments (10° spacing).
he circumferential profiles were transformed into a polar
ap (432 sub-segments) for all acquired image sets. To
void partial volume effects, the most apical slice was
xcluded from analysis. Signal intensity of remote and
nhanced myocardium was determined in a representative
lice over time. The size of myocardial enhancement at each
ime point was quantified using a threshold analysis with
ormalization to remote myocardium, which was set to
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Quantification of Infarct Size by MRI February 15, 2005:544–5200%. Thresholds of 160%, 175%, 200%, 225%,
250% were applied to quantify the extent of hyperen-
ancement as percentage of the LV.
PECT. Image analysis was performed by operators who
ere unaware of clinical information and MRI results. A
olar map approach developed in our laboratory and vali-
ated with phantom measurements was employed (19).
For quantitative assessment a volumetric sampling tool
as applied to create polar maps of identical size represent-
ng the relative distribution of activity throughout the LV.
he spatial sampling of the LV from apex to base was
atched to the selection of the MRI short-axis slices. Each
olar map was normalized to its own maximal value. The
ize of defect was calculated with the use of a threshold of
0% as derived from phantom studies and was quantified as
ercentage LV (6).
tatistics. Mean and SD are given for all continuous data.
o compare differences between signal intensity and en-
able 1. Patients’ Characteristics
Patient Age (yrs) Gender
Infarct
Location
Coronary
Artery
Disease
1 67 F INF 3
2 64 M ANT 3
3 60 M LAT 3
4 51 M ANT 3
5 75 F ANT 3
6 72 F INF 1
7 35 M ANT 1
8 82 M INF 2
9 68 M INF 1
10 67 M INF 1
11 67 M ANT 1
12 64 M INF 1
13 53 M INF 1
14 61 M ANT 1
15 42 M INF 2
16 75 F INF 2
17 66 M ANT 3
18 47 M INF 3
19 78 F ANT 3
20 60 M ANT 1
21 70 M ANT 3
22 37 M INF 2
23 67 M LAT 1
24 62 M INF 2
25 74 M ANT 3
26 55 M ANT 3
27 59 M INF 3
28 35 F ANT 1
29 51 M ANT 3
30 53 M INF 1
31 67 M ANT 1
32 64 M INF 3
33 70 F INF 2
All (mean  SD) 61  12
agnetic resonance imaging infarct size was measured at 28 min after contrast usin
ANT  anterior; CK  creatine kinase; EF  ejection fraction; INF  inferior;
left ventricle; MRI  magnetic resonance imaging; RCA  right coronary arteryancement size for different TIs as well as CK levels tepending on prior fibrinolysis, a two-tailed t test was used.
inear regression analysis was used for the comparison of
nhancement size by CeMRI with SPECT perfusion de-
ect, peak CK, and LV ejection fraction (EF). Further
omparison of CeMRI and SPECT was performed by
land-Altman analysis. A value of p  0.05 was considered
tatistically significant.
ESULTS
tudy population. Table 1 summarizes the clinical data of
he patient population. A total of 15 patients had anterior,
6 had inferior, and 2 had lateral MI; 8 patients underwent
ntravenous fibrinolysis before catheterization. Successful
oronary intervention including stent implantation of the
nfarct-related artery (left anterior descending artery n 15,
ight coronary artery n  15, left circumflex artery n  3)
as performed in all 33 patients on the day of admission; 13
atients had one-vessel, 6 had two-vessel, and 14 had
rct-Related
Artery
Peak CK
(U/l) EF (%)
Infarct Size
SPECT
(%LV)
Infarct Size
MRI
(%LV)
RCA 1,090 59 0 3
LAD 350 59 3 14
LCX 519 55 1 0
LAD 2,051 35 22 18
LAD 495 22 38 32
RCA 1,070 45 5 0
LAD 1,299 47 11 24
RCA 956 — 10 13
RCA 219 58 5 0
RCA 733 36 23 12
LAD 525 57 35 25
RCA 117 73 2 0
RCA 431 57 2 6
LAD 1,150 48 6 11
RCA 1,277 40 24 25
RCA 682 60 2 3
LAD 1,744 59 42 43
LCX 1,765 39 20 31
LAD 80 42 40 25
LAD 78 65 2 2
LAD 945 26 17 23
RCA 80 47 7 14
LCX 1,001 56 1 9
RCA 1,082 46 21 22
LAD 1,580 28 68 50
LAD 701 48 15 0
RCA 637 51 9 1
LAD 888 52 20 16
LAD 728 19 12 18
RCA 771 58 17 12
LAD 892 45 14 22
RCA 270 55 1 1
RCA 843 43 7 9
867  477 48  12 15  15 15  13
djusted inversion time and a threshold of 200% remote.
 left anterior descending artery; LAT  lateral; LCX  left circumflex artery; LV
CT  single-photon emission computed tomography.Infa
g an ahree-vessel disease. Left ventricular EF, assessed by ven-
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February 15, 2005:544–52 Quantification of Infarct Size by MRIriculography during reperfusion therapy, was 48  12%.
eak CK level after infarction averaged 867 477 U/l in all
atients (744  395 U/l without, 1,223  512 U/l with
rior fibrinolysis; p  0.01).
eMRI. SIGNAL INTENSITY. Figure 1 shows CeMRI ex-
mples of a representative slice in different infarct regions
ver time. Myocardial infarction was correctly localized by
E in all patients. A total of 7 min after injection of contrast
gent, infarct regions already displayed a clear increase of signal
ntensity compared with remote myocardium. Using different
I strategies showed a moderate effect on signal intensity in
emote myocardium. A marked signal decrease in enhanced
egions on later acquisitions was observed if the TI was held
onstantly at 300 ms over time (Fig. 2A). As compared with
emote, the signal intensity for both strategies peaked at 21
in after contrast (478% vs. 477%) and remained at 437% after
2 min for TI adjustment but decreased to 358% for a constant
I (Fig. 2B, Table 2).
YOCARDIAL CE. Figure 1 displays the extent of hyperen-
ancement within infarcted myocardium of three patients
ver time. Enhancement was detectable 7 min after injec-
igure 1. Time course of contrast-enhanced magnetic resonance imaging
ifferent infarct regions. (Upper row) Adjusted inversion time (TI); (
ontrast-enhanced MRI showed a decrease of signal intensity and extent
olumn) Corresponding single-photon emission computed tomography (SP
ays after infarction (creatine kinase [CK] 431 U/l); (B) subendocardial inf
C) transmural infarction of the inferior, inferoseptal, and inferolateral w
ypoperfusion, which disappeared on later acquisitions.ion of contrast agent. Extent of enhancement varied over oime independent of the chosen threshold (Fig. 3A). The
ean extent peaked at 14 min after contrast and subse-
uently decreased. Figure 3B shows the influence of TI on
he enhancement extent for a threshold of200% of remote
yocardium. For MRI performed using an adjusted TI, the
xtent of enhancement varied from 18.2 at 14 min to 12.7%
V at 42 min. In contrast, when TI was held constant at
00 ms, the enhancement extent significantly decreased
fter the 28th min.
omparison of MRI CE with measures of infarct size.
PECT. Figure 4 shows examples of the extent of myo-
ardial CE and the corresponding SPECT perfusion defect
n different infarct regions.
The SPECT perfusion defect within infarct regions
veraged 15.2  15% of the LV with a mean Tc-99m-
estamibi uptake of 40 9%. Quantification of the extent of
yocardial CE based on a threshold of160% and175%
f remote myocardium overestimated, whereas a threshold
f 225% and 250% underestimated, the mean SPECT
erfusion defect. Using a threshold of 200% showed the
est agreement of enhancement extent with measurements
I) delayed myocardial enhancement in a representative short-axis slice of
row) constant TI of 300 ms. Using a constant TI of 300 ms for
hancement on later acquisitions compared with an adjusted TI. (Right
) perfusion defect. (A) Transmural infarction of the inferoseptal wall eight
n of the anteroseptal wall seven days after the acute event (CK 1,150 U/l);
x days after infarction (CK 1,765 U/l) showing an early subendocardial(MR
lower
of en
ECT
arctio
all sif perfusion defect by SPECT (Figs. 3A and 3B).
u
S
a
i
3
i
L
d

w
w
t
t
c
3
C
o
s
d
c
r
e
c
m
D
A
w
l
r
a
c
j
c
d

a
i
l
i
r
P
b
s
d
h
a
p
h
M
b
t
s
b
t
F
e
R
r
C
t
T
I
S
E
C
C
E
E
C
548 Ibrahim et al. JACC Vol. 45, No. 4, 2005
Quantification of Infarct Size by MRI February 15, 2005:544–52Figure 3C shows the individual difference for MRI CE
sing a threshold 200% of remote myocardium and
PECT perfusion defect. Using an adjusted TI, CeMRI
nd SPECT showed a good agreement for quantification of
nfarct size at all time points within an average difference of
% of the LV. The best concurrence between both modal-
ties was found at 28 min after contrast (MRI: 14.7  13%
V, SPECT: 15.2  15% LV) yielding the lowest mean
ifference of 0.6  8% LV and the highest correlation (r
0.86, slope: 0.72) (Figs. 5A and 5B, Table 2). If the TI
as held constant at 300 ms, CeMRI and SPECT agreed
ell until 21 min after contrast injection. However, due to
he decrease of myocardial enhancement on later acquisi-
ions, the mean difference between both modalities in-
igure 2. (A) Measurement of mean signal intensity in normal and
nhanced myocardium over time using different inversion times. (B)
elation of mean signal intensity in infarct regions in comparison with
emote myocardium over time for different inversion times (p  0.02).
eMRI contrast-enhanced magnetic resonance imaging; TI inversion
ime.
able 2. CeMRI Myocardial Enhancement Over Time in Comp
nfarct Size
Time After Contrast Injection (min) 7’ 14’
ignal intensity (% remote) 434  152 475  15
nhancement size (% LV) 17.5  18 18.2  15
eMRI-SPECT (% LV) 2.3  13 3.0  9
eMRI vs. SPECT (r value) 0.70 0.84
nhancement size vs. CK (r value) 0.57 0.61
nhancement size vs. EF (r value) 0.41 0.53ontrast-enhanced magnetic resonance imaging (CeMRI) was performed with an adjusted
CK  creatine kinase; EF  ejection fraction; LV  left ventricle; SPECT  single-preased to about 7% of the LV myocardium at 42 min (Fig.
C).
K AND EF. Comparison of the extent of myocardial CE
ver time with peak CK and LV EF as measures of infarct
ize yielded lower correlations than SPECT perfusion
efect (Table 2). For CK and EF, the correlation coeffi-
ients ranged from r  0.57 to 0.71 and 0.25 to 0.58,
espectively. Figure 6 shows the correlation for both param-
ters with the myocardial enhancement size 28 min after
ontrast injection using a threshold of 200% of remote
yocardium.
ISCUSSION
ll patients with reperfused AMI displayed myocardial CE
ithin infarcted regions, and all infarcts were correctly
ocalized by CeMRI seven days after the acute event. The
esults of this study demonstrate that the signal intensity
nd extent of enhanced regions varies with time after
ontrast injection and with the chosen TI. Using an ad-
usted TI, CeMRI infarct size was stable over time after
ontrast injection and matched well with the myocardial
efect size by Tc99m-sestamibi SPECT for a threshold of
200% of remote myocardium. A fixed TI of 300 ms
llowed comparable assessment until 21 min after contrast
njection but underestimated SPECT perfusion defect on
ater acquisitions; CeMRI can accurately assess myocardial
nfarct size, but standardization of the imaging protocol is
equired.
athophysiology of CE in MI. Myocardial enhancement
y extracellular contrast agents like Gd-DTPA have been
hown to occur in different conditions of myocardial tissue
amage. The exact relationship of the observed hyperen-
anced regions to the underlying pathophysiology has been
subject of debate; Gd-DTPA is biologically inert and
assively diffuses throughout the extracellular space with a
alf-time in blood of approximately 20 min (20). In chronic
I, CE represents irreversible injured tissue, which has
een shown in animal and patient studies (8,21). However,
he mechanism of delayed enhancement in acute and
ubacute MI is less defined.
Myocardial enhancement is a function of delivery, distri-
ution, and washout of contrast agent within infarcted
issue. The delivery to areas of MI is dependent on the
With SPECT Perfusion Defect and Other Parameters of
21’ 28’ 35’ 42’
478  182 474  151 447  198 437  146
16.6  13 14.7  13 12.9  10 12.7  10
1.4  9 0.6  8 0.8  7 1.1  6
0.82 0.86 0.77 0.79
0.60 0.60 0.71 0.70
0.58 0.52 0.38 0.25arison
6inversion time and quantified based on a threshold 200% of remote myocardium.
hoton emission computed tomography.
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February 15, 2005:544–52 Quantification of Infarct Size by MRIatency of the infarct-related artery and on the microvas-
ular perfusion. Once the contrast media reaches the in-
arcted tissue, it distributes into the extravascular space.
vidence suggests that concentrations of contrast agents
nd the partition coefficient are increased in regions of acute
nfarction (22). This can be explained by an increase of
igure 3. (A) Measurement of mean myocardial enhancement extent by
ontrast-enhanced magnetic resonance imaging (CeMRI) (adjusted inver-
ion time [TI]) over time based on different threshold analysis in compar-
son with remote myocardium and mean Tc99m-sestamibi single-photon
mission computed tomography (SPECT) perfusion defect. (B) Mean
yocardial enhancement extent by CeMRI over time based on a threshold
nalysis of 200% of remote myocardium. If the TI was held constant at
00 ms, the mean enhancement size significantly decreased on acquisitions
fter the 28th min postcontrast in comparison with CeMRI performed
ith an adjusted TI (p  0.03). (C) Mean difference of CeMRI and
PECT over time. Mean difference was calculated between the size of
yocardial contrast-enhancement by CeMRI based on a threshold200%
f remote myocardium and the size of SPECT perfusion defect within
very patient. Using an adjusted TI CeMRI and SPECT showed a good
greement at all time points within an average difference of 3% of the left
entricular (LV) myocardium. For a constant TI of 300 ms, both
odalities agreed well until 21 min after contrast injection; however, on
ater acquisitions the mean difference increased to about 7% of the LV
yocardium at 42 min (p  0.03).istribution volume for the contrast agent, which may be aaused by myocyte necrosis, edema, or inflammation with
ncreased capillary permeability. In a previous study, it has
een demonstrated that regions of hyperenhancement were
ssociated with sarcomere membrane rupture examined by
lectron microscopy (15). After infarction, the loss of
arcomere membrane integrity, which is thought to be
ightly related to cell death (23), allows Gd-DTPA to
assively distribute into previous intracellular space. This
ffects myocardial Gd-DTPA kinetics because additional
ime is required for contrast molecules to diffuse in and out
f isolated breaks in the cellular membrane. This has been
hown for other markers with similar molecular weight as
d-DTPA after myocyte death (24) as well as in AMI,
here marked changes of wash-in and washout kinetics of
d-DTPA within rim and core regions of infarcted tissue
ere observed as compared with normal myocardium (15).
uantification of myocardial enhancement. For the
uantitative assessment of myocardial enhancement, we
eveloped a polar map approach similar to myocardial
erfusion imaging with nuclear imaging techniques ac-
ounting for the three-dimensional geometry of the LV
19). To compare CeMRI to SPECT studies with lower
patial resolution, myocardial enhancement was only ana-
yzed transmurally.
Enhanced regions were normalized using a threshold
nalysis in comparison with remote myocardium, which
erved as a reference region in numerous other CeMRI
tudies (8–10,12,15). Contrast thresholds 200% of re-
ote myocardium (100%) yielded best agreement with 50%
hreshold used in SPECT studies for assessment of perfu-
ion defects. As shown in this study, the defined threshold
ffects the size of enhancement substantially and underlines
he importance of standardization and calibration of analysis
ecause different authors have introduced different cutoff
alues (8,9,12,15).
ime course of CE early after reperfused AMI. The
esults of this study show that the signal intensity and extent
f hyperenhancement changed over time after contrast
njection. All patients examined in this study had a success-
ul reperfusion of the infarct-related artery ensuring com-
arable delivery of contrast agent. Recently, Oshinski et al.
18) demonstrated that the size of the enhanced region
aries with the time imaging is performed after Gd-DTPA
njection in a rat model of reperfused AMI. They found that
he true infarct size as assessed by TTC-staining was
verestimated by 20% to 40% immediately after contrast
njection and that the time for the enhanced region to
orrespond to the true infarct size was 21  4 min.
Because of the use of contrast agents such as Gd-DTPA
ith complex diffusion properties, myocardial enhancement
s a marker of tissue injury is a time-dependent process. It
eflects the underlying pathophysiology of different tissue
onditions within the infarcted regions. Close inspection of
he methodology of different studies reveals substantial
ifferences in acquisition timing after injection of contrast
gent (time intervals of 5 up to 60 min), which might
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Quantification of Infarct Size by MRI February 15, 2005:544–52xplain the disparate results concerning accurate assessment
f infarct size by CeMRI (8–14).
Results of this study further show that the extent of
nhancement over time is dependent on the chosen TI. As
he blood concentration of Gd-DTPA decreases from 2.06
o 0.77 mmol/l from 1 to 40 min after injection, the correct
I in order to null normal myocardium increases and has,
herefore, to be adjusted (20). If the TI is kept constant, the
eriphery of the hyperenhanced region might pass through
zero-crossing, thereby affecting its apparent size. We
ound that if the TI was held constant, the extent of
nhancement decreases on later acquisitions. However,
sing an adjusted TI, the signal intensity was stable until 42
in after contrast injection.
omparison of myocardial enhancement with clinical
easures of infarct size. We demonstrated that myocar-
ial enhancement size moderately correlates with LV EF as
ssessed by left ventriculography during reperfusion therapy
nd peak CK levels. This reflects the difficulties for accurate
valuation of infarct size using methods that do not provide
egional characterization of irreversible myocardial tissue
njury (2).
Coronary artery reperfusion can dramatically change the
ashout kinetics of CK from myocardium, especially after
hrombolysis as performed in a subgroup of our patients
igure 4. Comparison of contrast-enhanced magnetic resonance imagin
omography (SPECT) perfusion defect with corresponding polar maps. Sh
nfarction of the inferior wall (day 6) with transmural contrast enhancemeesulting in early and exaggerated peak enzyme levels and, thus, limiting the usefulness of CK curves as a measure of
nfarct size (25).
Single-photon emission computed tomography imaging
ith Tc99m-sestamibi is currently the best available tool for
nfarct sizing in patients and has been used as surrogate end
oint in reperfusion trials after AMI (3). Tc99m-sestamibi
istributes according to myocardial blood flow and demon-
trates a slow washout with minimal delayed redistribution
ven after flow is restored in an occluded artery (26).
There are only a few studies in humans comparing
eMRI with SPECT perfusion imaging for the assessment
f infarct size after AMI (16,17). All these studies were
erformed using thallium-201 and showed that regions with
yperenhancement correlate well with fixed scintigraphic
efects (r  0.69 and r  0.92).
However, there have been no direct quantitative compar-
son between CeMRI and Tc99m-sestamibi SPECT after
MI using three-dimensional co-registration of both data
ets.
A major advantage of CeMRI compared with currently
sed SPECT is the higher spatial resolution, which makes
his technique suitable to detect small areas of subendocar-
ial infarcts (27). Furthermore, CeMRI can be combined
ith other magnetic resonance techniques such as estima-
MRI) at 28 min after contrast and single-photon emission computed
xis slices are orientated from apical (left) to basal (right). (A) Myocardial
) Anterior infarction (day 8) with subendocardial enhancement.g (Ce
ort-a
nt. (Bion of contractility by cine-MRI, magnetic resonance
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pproach for the assessment of myocardial viability.
tudy limitations. In this study, a segmented inversion
ecovery TrueFISP sequence was used to maximize acqui-
ition speed with high contrast for continuous imaging. The
aximal signal intensity of enhanced regions was approxi-
ately 475% of remote regions, which is comparable with
esults of other studies using spin-echo and gradient-echo
equences (15,18). A recently introduced fast-gradient echo
equence showed an increase of contrast-to-noise ratio,
hich may improve differentiation between injured and
ormal myocardium (28). However, as contrast character-
stics for the used Gd-DTPA concentration are primarily
1-dominated, the results of our study should be applicable
o other imaging techniques.
It has been shown that, with the TI 275 ms the
agnetization of normal myocardium, blood in the LV and
igure 5. Comparison of contrast-enhanced magnetic resonance imaging
CeMRI) at 28 min after contrast (threshold 200% of remote myocar-
ium) and single-photon emission computed tomography (SPECT). (A)
orrelation of enhancement size with SPECT perfusion defect. (B)
greement between both modalities depicted in a Bland-Altman graph
mean value of the differences  solid line; 2 SD  dotted line).
verage value of the two measurements is plotted along the x-axis; the
ifference is plotted along the y-axis. LV  left ventricle.n enhanced regions was above zero and differences between degions were less evident (28). The constant TI of 300 ms
e used was comparable with other studies, which observed
greement of hyperenhancement with extent of myocyte
ecrosis irrespective of reperfusion (8,28). Although a de-
ned TI would simplify the procedure of CeMRI, TI
djustment resulted in a smaller decrease of signal and
nhancement size over time.
Our analysis approach neglected the very apical portion of
he LV in order to minimize partial volume effects. How-
ver, this was performed consistently in all MRI and
PECT studies. Therefore, the “true” infarct size may have
een underestimated by both techniques.
In order to assume comparable pathophysiologic condi-
ions for the interpretation of CE in this study, only patients
ith successfully performed coronary intervention of the
nfarct-related artery were included. Results obtained may
ot be applicable to patients without reperfusion therapy
fter AMI because contrast kinetics may be different if the
nfarct-related artery is occluded and contrast agent cannot
igure 6. Myocardial contrast enhancement by contrast-enhanced mag-
etic resonance imaging (CeMRI) at 28 min after contrast (threshold
200% of remote myocardium) in comparison with peak creatine kinase
CK) level (A) and left ventricular (LV) ejection fraction assessed angio-
raphically on the day of admission (B).irectly reach the infarct region.
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uantify the extent of infarct regions in close agreement to
c99m-sestamibi SPECT early after reperfused AMI. Due
o the physiologic properties of extracellular contrast agents,
tandardized timing after contrast injection and acquisition
s important for accurate assessment of infarct size.
ontrast-enhanced MRI will be an attractive new method
o serve as a surrogate end point in clinical studies similar to
c99m-sestamibi SPECT.
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